Trevi Therapeutics (TRVI) Tops Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts TRVI Hot Sheet
Join SI Premium – FREE
Trevi Therapeutics (NASDAQ: TRVI) reported Q1 EPS of ($0.09), $0.04 better than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Faraday Future unveils nine robot models, prices start at $9,990
- Leidos wins $85m Air Force contract for aerospace design
- FortuneX and WT Realty announce $600M merger deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
